New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.

November 10, 2025

Roswell Park Comprehensive Cancer Center

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Roswell Park Comprehensive Cancer Center

Buffalo, NY
Key Differentiators
- Pediatric Oncology
- Hematology-Oncology
- Clinical Trials
#2

Children’s Oncology Group (COG)

Arcadia, CA
Key Differentiators
- Pediatric Oncology
- Clinical Trial Consortium
#3

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Adult and Pediatric Oncology
- Hematologic Malignancies
- Immunotherapy
#4

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology-Oncology
- Lymphoma Research
- Clinical Trials
#5

St. Jude Children’s Research Hospital

Memphis, TN
Key Differentiators
- Pediatric Oncology
- Hematologic Malignancies
- Survivorship Research